“…PFC against maternal and other erythrocyte antigens were commonly detected in human fetal liver, lymph nodes, spleen, or thymus as early as 16 weeks gestation and were usually more abundant in liver than in spleen after 16 weeks gestation. These data corroborate studies from other laboratories which indicate that human fetuses develop some forms of immunocompétence very early during gestation.positive mother [1,6], but there is little evidence to this effect.Hemolytic plaque-forming cells (PFC) reactive against a variety of natural and synthetic erythrocyte epitopes have been de scribed in both immunized and nonimmunized individuals in numerous species [3,4,8,13,14], Sensitive methods for enumer ating individual PFC [8], each producing a particular class of immunoglobulin [20] have served to delineate early events in the immune response to erythrocyte-bound anti gens [12], Methods developed in animal models, and used recently [8,12,20] to detect PFC among maternal peripheral blood leukocytes [9,11] were employed in this investigation to survey fetal and neonatal tis sues for immunocompetent cells directed against various erythrocyte-bound epitopes.
…”